Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis.
about
Atherosclerosis and infection: is the jury still not in?Immune modulation during latent herpesvirus infectionSocioeconomic status, pathogen burden and cardiovascular disease riskCytomegalovirus seropositivity and incident ischaemic heart disease in the Caerphilly prospective heart disease studyMCMV induces neointima in IFN-gammaR-/- mice: intimal cell apoptosis and persistent proliferation of myofibroblastsCytomegalovirus Hyper Immunoglobulin for CMV Prophylaxis in Thoracic TransplantationA novel nonnucleoside inhibitor specifically targets cytomegalovirus DNA maturation via the UL89 and UL56 gene products.Resistance of human cytomegalovirus to benzimidazole ribonucleosides maps to two open reading frames: UL89 and UL56Cytomegalovirus infection enhances the immune response to influenza.The modulation of tissue factor by endothelial cells during heat shock.Hepatitis C viremia is associated with cytomegalovirus IgG antibody levels in HIV-infected women.Dental plaque, platelets, and cardiovascular diseases.Long term vascular complications of Coxiella burnetii infection in Switzerland: cohort study.Coagulation initiated on herpesviruses.The influence of persistent pathogens on circulating levels of inflammatory markers: a cross-sectional analysis from the Multi-Ethnic Study of AtherosclerosisAn Unsettled Debate About the Potential Role of Infection in Pathogenesis of Atherosclerosis.Seropositivity to cytomegalovirus, inflammation, all-cause and cardiovascular disease-related mortality in the United States.Inflammation, infection and atherosclerosis: do antibacterials have a role in the therapy of coronary artery disease?Immunomodulation of atherosclerosis: myth and reality.Systemic infection and inflammation as trigger factors of ischemic stroke.Humoral immune response to human cytomegalovirus in patients undergoing percutaneous transluminal coronary angioplastyMicroorganisms in the aetiology of atherosclerosis.Common infections and the risk of stroke.Cytomegalovirus antibody levels, inflammation, and mortality among elderly Latinos over 9 years of follow-up.Human cytomegalovirus causes endothelial injury through the ataxia telangiectasia mutant and p53 DNA damage signaling pathways.The role of risk factors in the development of atherosclerosis.Cytomegalovirus enhances macrophage TLR expression and MyD88-mediated signal transduction to potentiate inducible inflammatory responses.Cytomegalovirus seropositivity is associated with increased arterial stiffness in patients with chronic kidney disease.Hepatitis B virus infection and coronary atherosclerosis: results from a population with relatively high prevalence of hepatitis B virus.Increased carotid intima-media thickness associated with antibody responses to varicella-zoster virus and cytomegalovirus in HIV-infected patients.Enhanced cytomegalovirus infection in atherosclerotic human blood vessels.Atherosclerosis and Alzheimer--diseases with a common cause? Inflammation, oxysterols, vasculatureMetagenomic epidemiology: a new frontier.Acute cytomegalovirus infection and transient carotid intimal-medial thickening in a young, otherwise healthy womanCytomegalovirus immunoglobulin G antibody is associated with subclinical carotid artery disease among HIV-infected women.Presence of Periodontopathic Bacteria DNA in Atheromatous Plaques from Coronary and Carotid Arteries.Persistent infection and vascular disease: a systematic review.Does cytomegalovirus play a causative role in the development of various inflammatory diseases and cancer?Interferon gamma regulates acute and latent murine cytomegalovirus infection and chronic disease of the great vessels.Vaccination with synthetic constructs expressing cytomegalovirus immunogens is highly T cell immunogenic in mice.
P2860
Q22241306-26B56FEA-853E-4442-B2CF-1B65CF326800Q24624044-271FBB47-D6FD-4B2F-B0CC-35A181BCD4CFQ24669772-48873A48-8521-45E2-B11D-6E1E309E8009Q24683839-FBB2CF89-A2B3-4DA2-AA63-822D2042AE81Q24802883-30FC7E51-2182-4AF5-8F5C-5EF883D8AD8FQ26768477-D9028991-FEEF-44C2-9A6A-36C8A793296DQ28348812-C7B1ADDA-A01C-4FA6-9105-C5262A6C02F8Q28379493-68E5A40D-8EA6-4C73-A139-2482E97B06FCQ30300254-D8B6C69A-99D4-4AEF-A527-9084CC685C20Q30882582-6C4EB0D0-B1AD-4EC5-A8BE-657A064B1CE7Q31115875-49D49287-3A2F-44A2-99B1-A71D9803426BQ33503491-DB3642E6-DEEA-4E26-A175-68398E4901CBQ33634694-49503A0C-C354-4FE1-9C11-972267C6C76DQ33709008-E3E0AED1-3187-439E-990D-000377577B36Q33749010-56669197-90A6-4302-B3F0-54FF5579499DQ33763278-C867F131-EB26-40D7-B534-824424B9D82FQ33838430-FBA23DC7-00CA-4811-B975-87E95412DD89Q33871329-0EAB9069-D876-487C-A9A3-3CDE0D4EDBD1Q33890414-E7F8C9BE-BA07-4893-9157-6A55E15F6D44Q33979482-0A00108D-8C8A-49C1-B567-2048D3D36C10Q33997521-B5BB5BDD-6BB1-423C-83A8-3628462E94EAQ34065709-4D6AFA62-9F88-4870-ADF3-41280802CF3EQ34148785-5F169186-EFF3-46BF-B1B3-5D90DAD7602EQ34179430-197C8973-7D26-407E-9096-86A5E282A1F6Q34312528-40651C7D-DDE4-42D5-B0F2-6EECD13C0DCAQ34447107-7DFF785C-85D8-4CD6-9F13-BEC541D79CBAQ34550472-4DED9C60-18E4-4156-9A72-B42882257006Q34602254-E3C52DBC-9BA0-42C7-BB7B-9E47E1632633Q34605079-ECA2998E-C677-4F07-B674-C3A9D69F6737Q34745721-E52C0E8E-6F8D-47DF-A576-9CE39DF7CA2EQ35083494-C5230872-6C50-4EB0-852A-9719BBE3ACF1Q35127516-A634BD44-4DFA-4E0B-B2D7-7EB0AD3D6A31Q35271945-2B828BE8-B663-4C94-8AEE-2521FFE64BF5Q35638173-1B1E2632-AED6-4C19-8789-90E55F82EC73Q36154044-78114557-2CA0-4279-9EA0-CB709C7C1C93Q36172975-7C2B73C5-4AC6-4E77-ACC5-F815DA6F33EEQ36181163-AECC918E-C6D9-4A96-9DA9-3DE0CEF7A81FQ36395715-2FBD2C26-A072-494A-A462-4FED632355FFQ36401507-4DD37C94-F5F0-4831-B0B6-35B410025F5BQ36694861-86C9AFB4-8BF8-4050-BE09-2DD8BC0581B5
P2860
Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
Cohort study of cytomegaloviru ...... f subclinical atherosclerosis.
@en
Cohort study of cytomegaloviru ...... f subclinical atherosclerosis.
@nl
type
label
Cohort study of cytomegaloviru ...... f subclinical atherosclerosis.
@en
Cohort study of cytomegaloviru ...... f subclinical atherosclerosis.
@nl
prefLabel
Cohort study of cytomegaloviru ...... f subclinical atherosclerosis.
@en
Cohort study of cytomegaloviru ...... f subclinical atherosclerosis.
@nl
P2093
P921
P356
P1433
P1476
Cohort study of cytomegaloviru ...... f subclinical atherosclerosis.
@en
P2093
Comstock GW
Farzadegan H
Melnick JL
P304
P356
10.1161/01.CIR.94.5.922
P407
P577
1996-09-01T00:00:00Z